For this supplement, expert faculty provided detailed perspectives based on their extensive experience in the management of non–small-cell lung cancer (NSCLC), focusing on the incorporation and considerations for biomarker testing in precision medicine.
To sign up for our newsletter or print publications, please enter your contact information below.